DRD5 Antikörper (AA 361-477) (HRP)
-
- Target Alle DRD5 Antikörper anzeigen
- DRD5 (Dopamine Receptor D5 (DRD5))
-
Bindungsspezifität
- AA 361-477
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DRD5 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human D(1B) dopamine receptor protein (361-477AA)
- Isotyp
- IgG
- Top Product
- Discover our top product DRD5 Primärantikörper
-
anti-Dopamine Receptor D5 (DRD5) (AA 361-477) antibody
DRD5 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D5 (DRD5) (AA 323-477) antibodyDRD5 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D5 (DRD5) (Internal Region) antibodyVerified DRD5 Reaktivität: Human ELISA, IF, FACS Wirt: Ziege Polyclonal unconjugated
anti-Dopamine Receptor D5 (DRD5) (2nd Extracellular Loop), (AA 199-211) antibodyDRD5 Reaktivität: Maus, Ratte WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D5 (DRD5) (AA 251-350) antibodyDRD5 Reaktivität: Maus, Ratte WB, ELISA, IHC (p), FACS, IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D5 (DRD5) (AA 421-456), (C-Term) antibodyDRD5 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB52763 unconjugated
anti-Dopamine Receptor D5 (DRD5) (Extracellular Domain) antibodyDRD5 Reaktivität: Human, Ratte IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D5 (DRD5) (Cytoplasmic Domain) antibodyDRD5 Reaktivität: Human, Hund IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D5 (DRD5) (N-Term) antibodyDRD5 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D5 (DRD5) (AA 19-56), (N-Term) antibodyDRD5 Reaktivität: Maus WB Wirt: Kaninchen Polyclonal RB52770 unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- DRD5 (Dopamine Receptor D5 (DRD5))
- Andere Bezeichnung
- DRD5 (DRD5 Produkte)
- Hintergrund
-
Background: Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.
Aliases: D(1B) dopamine receptor antibody, D(5) dopamine receptor antibody, D1 beta dopamine receptor antibody, D1B dopamine receptor antibody, D1beta dopamine receptor antibody, D5 dopamine receptor antibody, DBDR antibody, Dopamine D5 receptor antibody, Dopamine receptor D1B antibody, dopamine receptor D5 antibody, DRD 1B antibody, DRD 5 antibody, DRD1B antibody, DRD1L2 antibody, DRD5 antibody, DRD5_HUMAN antibody, MGC10601 antibody
- UniProt
- P21918
- Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of long-term Neuronal Synaptic Plasticity
-
